583 related articles for article (PubMed ID: 25810009)
21. Novel chemotherapeutics and other therapies for treating high-grade glioma.
Kang JH; Adamson C
Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
[TBL] [Abstract][Full Text] [Related]
22. Targeted molecular therapy of malignant gliomas.
Kesari S; Ramakrishna N; Sauvageot C; Stiles CD; Wen PY
Curr Neurol Neurosci Rep; 2005 May; 5(3):186-97. PubMed ID: 15865884
[TBL] [Abstract][Full Text] [Related]
23. Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas.
Morris PG; Abrey LE
Target Oncol; 2010 Sep; 5(3):193-200. PubMed ID: 20844972
[TBL] [Abstract][Full Text] [Related]
24. Multidisciplinary management of childhood brain tumors: a review of outcomes, recent advances, and challenges.
Pollack IF
J Neurosurg Pediatr; 2011 Aug; 8(2):135-48. PubMed ID: 21806354
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxic and molecular chemotherapy for high-grade glioma: an emerging strategy for the future.
Cavaliere R; Newton H
Expert Opin Pharmacother; 2006 Apr; 7(6):749-65. PubMed ID: 16556090
[TBL] [Abstract][Full Text] [Related]
26. Current and emerging molecular targets in glioma.
Roesler R; Brunetto AT; Abujamra AL; de Farias CB; Brunetto AL; Schwartsmann G
Expert Rev Anticancer Ther; 2010 Nov; 10(11):1735-51. PubMed ID: 21080801
[TBL] [Abstract][Full Text] [Related]
27. Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions.
Patel M; Vogelbaum MA; Barnett GH; Jalali R; Ahluwalia MS
Expert Opin Investig Drugs; 2012 Sep; 21(9):1247-66. PubMed ID: 22731981
[TBL] [Abstract][Full Text] [Related]
28. Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment.
Ellert-Miklaszewska A; Poleszak K; Kaminska B
Future Med Chem; 2017 Jan; 9(2):199-221. PubMed ID: 28111982
[TBL] [Abstract][Full Text] [Related]
29. Targeting different domains of gap junction protein to control malignant glioma.
Wang J; Yang ZY; Guo YF; Kuang JY; Bian XW; Yu SC
Neuro Oncol; 2018 Jun; 20(7):885-896. PubMed ID: 29106645
[TBL] [Abstract][Full Text] [Related]
30. Treatment of adults with recurrent malignant glioma.
Nabors LB; Fiveash J
Expert Rev Neurother; 2005 Jul; 5(4):509-14. PubMed ID: 16026234
[TBL] [Abstract][Full Text] [Related]
31. Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas.
Lo HW
Curr Cancer Drug Targets; 2010 Dec; 10(8):840-8. PubMed ID: 20718706
[TBL] [Abstract][Full Text] [Related]
32. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas.
Juratli TA; Qin N; Cahill DP; Filbin MG
Pharmacol Ther; 2018 Feb; 182():70-79. PubMed ID: 28830841
[TBL] [Abstract][Full Text] [Related]
34. Promising new therapies for malignant gliomas.
Fine HA
Cancer J; 2007; 13(6):349-54. PubMed ID: 18032970
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells and malignant gliomas. From pathophysiology to targeted molecular therapy.
Florian IS; Tomuleasa C; Soritau O; Timis T; Ioani H; Irimie A; Kacso G
J BUON; 2011; 16(1):16-23. PubMed ID: 21674845
[TBL] [Abstract][Full Text] [Related]
36. Primetime for antiangiogenic therapy.
Tabatabai G; Stupp R
Curr Opin Neurol; 2009 Dec; 22(6):639-44. PubMed ID: 19786873
[TBL] [Abstract][Full Text] [Related]
37. Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies.
Argyriou AA; Antonacopoulou A; Iconomou G; Kalofonos HP
Crit Rev Oncol Hematol; 2009 Mar; 69(3):199-210. PubMed ID: 18602834
[TBL] [Abstract][Full Text] [Related]
38. Targeted therapy in gliomas.
Hamza MA; Gilbert M
Curr Oncol Rep; 2014 Apr; 16(4):379. PubMed ID: 24510741
[TBL] [Abstract][Full Text] [Related]
39. Investigational new drugs for brain cancer.
Staedtke V; Bai RY; Laterra J
Expert Opin Investig Drugs; 2016 Aug; 25(8):937-56. PubMed ID: 27170161
[TBL] [Abstract][Full Text] [Related]
40. Conventional chemotherapy and perspectives for molecular-based oncological treatment in pediatric hemispheric low-grade gliomas.
Fernández MB; Alonso VP
Childs Nerv Syst; 2016 Oct; 32(10):1939-45. PubMed ID: 27659836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
